Retatrutide 32mg Pre-Filled Injectable Pen is a next-generation triple agonist therapy that supports weight reduction, appetite control, and better metabolic health. With its powerful formulation, this once-weekly pen combines GLP-1, GIP, and Glucagon receptor activity to help individuals achieve long-term fat loss results in South Africa.

How Retatrutide Works

This advanced formula targets three critical metabolic pathways:

• GLP-1: reduces appetite, slows digestion, and helps maintain stable blood sugar after meals.

• GIP: enhances satiety and assists with post-meal glucose management.

• Glucagon receptor activity: increases metabolic efficiency and supports fat burning for energy.

Together, these actions encourage consistent calorie reduction, improved insulin balance, and effective weight loss.

Key Advantages

• Promotes sustainable fat loss with a triple-agonist approach

• Helps reduce cravings and overeating

• Supports blood sugar regulation and metabolic balance

• Delivered in a convenient once-weekly pre-filled pen

• Backed by Body Pharm quality for trusted results

Suggested Dosing Guide

The pen includes a dosage selector for gradual adjustment:

• Week 1–4: 2 mg

• Week 5–8: 4 mg

• Week 9–12: 6 mg

• Week 13–16: 8 mg

• From Week 17 onwards: 12 mg

Continue at the dose that maintains appetite control and consistent weight reduction, under professional supervision.